Albemarle Corporation (ALB) Income Statement
ALB 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsALB revenue and net income
Where ALB's revenue goes
2025Each bar shows an amount and its share of revenue. ALB kept −9.9% of revenue as net income.
ALB profit margins
ALB growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | −4.4% | −11.1% | +10.4% | +6.2% |
| Gross profit | +1,014.9% | −39.8% | −7.6% | −2.4% |
| Operating income | — | −66.5% | −29.2% | −14.9% |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
ALB quarterly EPS vs estimates
Albemarle beat the analyst EPS estimate in 5 of the last 8 quarters. Next report: November 4, 2026 (estimate $2.44).
ALB income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.14B | $5.38B | $9.62B | $7.32B | $3.33B | $3.13B | $3.59B | $3.37B | $3.07B | $2.68B |
| Cost of revenue | $4.47B | $5.32B | $8.42B | $4.23B | $2.32B | $2.13B | $2.33B | $2.15B | $1.95B | $1.71B |
| Gross profit | $671.6M | $60.2M | $1.20B | $3.09B | $1.01B | $995.6M | $1.26B | $1.22B | $1.12B | $970.6M |
| Research & development | $51.4M | $86.7M | $85.7M | $72.0M | $54.0M | $59.2M | $58.3M | $70.1M | $84.3M | $80.5M |
| Sales, general & admin | $550.0M | $618.0M | $873.4M | $524.1M | $441.5M | $429.8M | $533.4M | $446.1M | $437.9M | $380.5M |
| Total operating expenses | $577.8M | $696.2M | $959.9M | $584.1M | $475.8M | $469.8M | $573.5M | $496.7M | $500.9M | $460.9M |
| Operating income | $93.8M | −$636.0M | $241.1M | $2.50B | $532.7M | $525.7M | $685.3M | $724.3M | $622.6M | $509.6M |
| Interest income | $196.6M | $236.3M | $110.6M | $123.0M | $61.5M | $68.3M | $78.7M | $72.3M | $58.0M | $65.2M |
| Interest expense | $207.7M | $165.6M | $116.1M | $123.0M | $61.5M | $73.1M | $57.7M | $52.4M | $115.3M | $65.2M |
| Income before taxes | −$308.3M | −$1.05B | $2.10B | $3.21B | $229.4M | $501.0M | $692.5M | $884.0M | $531.3M | $574.9M |
| Income taxes | $156.9M | $87.1M | $430.3M | $390.6M | $29.4M | $54.4M | $88.2M | $144.8M | $431.8M | $96.3M |
| Net income | −$510.6M | −$1.18B | $1.57B | $2.69B | $123.7M | $375.8M | $533.2M | $693.6M | $54.9M | $643.7M |
| EBITDA | $558.0M | −$294.1M | $2.65B | $3.63B | $544.9M | $757.7M | $898.8M | $925.0M | $819.5M | $735.8M |
| EPS (diluted) | −$0.79 | −$2.34 | $22.24 | $21.95 | $4.05 | $4.12 | $6.04 | $5.50 | $4.60 | $3.90 |
| Gross margin | 13.1% | 1.1% | 12.5% | 42.2% | 30.3% | 31.8% | 35.1% | 36.2% | 36.6% | 36.3% |
| Operating margin | 1.8% | −11.8% | 2.5% | 34.2% | 16.0% | 16.8% | 19.1% | 21.5% | 20.3% | 19.0% |
| Net margin | −9.9% | −21.9% | 16.4% | 36.7% | 3.7% | 12.0% | 14.9% | 20.6% | 1.8% | 24.0% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.74B | $1.43B | $1.43B | $1.31B | $1.33B | $1.08B | $1.23B | $1.35B | $1.43B | $1.36B | $2.36B | $2.31B |
| Cost of revenue | $1.15B | $927.8M | $1.23B | $1.19B | $1.13B | $922.5M | $1.09B | $1.46B | $1.44B | $1.32B | $3.05B | $2.25B |
| Gross profit | $590.3M | $501.0M | $202.7M | $117.6M | $196.9M | $154.4M | $138.2M | −$104.0M | −$10.6M | $36.0M | −$690.7M | $57.6M |
| Research & development | $3.7M | $9.2M | $12.2M | $12.7M | $12.4M | $14.1M | $20.0M | $22.4M | $20.8M | $23.5M | $22.8M | $21.1M |
| Sales, general & admin | $126.4M | $137.4M | $155.5M | $138.6M | $132.5M | $123.5M | $136.0M | $154.3M | $168.9M | $194.9M | $194.3M | $173.9M |
| Total operating expenses | $137.4M | $267.5M | $154.5M | $148.1M | $143.1M | $136.9M | $153.7M | $176.1M | $180.5M | $180.0M | $203.4M | $182.4M |
| Operating income | $452.9M | $233.5M | $48.3M | −$30.5M | $53.7M | $17.5M | −$15.5M | −$280.1M | −$191.1M | −$144.0M | −$894.1M | −$124.8M |
| Interest income | — | — | $49.8M | $43.0M | $49.9M | $54.0M | $49.5M | $52.8M | — | — | — | $29.3M |
| Interest expense | $30.9M | $33.1M | $57.8M | $51.0M | $49.9M | $49.0M | $44.7M | $47.8M | $35.2M | $38.0M | $34.4M | $29.3M |
| Income before taxes | $441.6M | $254.2M | −$244.4M | −$178.5M | $69.3M | $45.3M | $95.7M | −$949.8M | −$207.3M | $12.9M | −$484.4M | $312.1M |
| Income taxes | −$57.6M | $21.5M | $157.3M | −$30.6M | $34.1M | −$4.0M | $10.6M | $110.9M | −$30.7M | −$3.7M | $118.9M | −$8.6M |
| Net income | $480.0M | $319.1M | −$414.2M | −$160.7M | $22.9M | $41.3M | $75.3M | −$1.07B | −$188.2M | $2.4M | −$617.7M | $302.5M |
| EBITDA | $620.0M | $445.1M | −$22.9M | $36.9M | $288.0M | $256.1M | $303.5M | −$738.5M | −$33.8M | $174.6M | −$305.9M | $446.9M |
| EPS (diluted) | $3.75 | $2.95 | −$0.53 | −$0.19 | $0.11 | −$0.18 | −$1.09 | −$1.55 | $0.04 | $0.26 | $1.85 | $2.74 |
| Gross margin | 33.9% | 35.1% | 14.2% | 9.0% | 14.8% | 14.3% | 11.2% | −7.7% | −0.7% | 2.6% | −29.3% | 2.5% |
| Operating margin | 26.0% | 16.3% | 3.4% | −2.3% | 4.0% | 1.6% | −1.3% | −20.7% | −13.4% | −10.6% | −37.9% | −5.4% |
| Net margin | 27.5% | 22.3% | −29.0% | −12.3% | 1.7% | 3.8% | 6.1% | −78.9% | −13.2% | 0.2% | −26.2% | 13.1% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in ALB's financial statements (latest annual report filed February 11, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
ALB financial results
In fiscal year 2025 (ended December 31, 2025), Albemarle reported revenue of $5.1 billion, down 4.4% from the year before. It had a net loss of $510.6 million, a net profit margin of −9.9%. Diluted earnings per share came to −$0.79. Over five years revenue grew at an average rate of 10.4% a year.
See the ALB stock overview for the latest quote and news, or the ALB chart for price history and technical indicators.
ALB income statement FAQ
What is Albemarle's annual revenue?
Albemarle reported total revenue of $5.1 billion for fiscal year 2025, which ended on December 31, 2025. That was down 4.4% from $5.4 billion the previous year.
Is Albemarle profitable?
No. Albemarle reported a net loss of $510.6 million in fiscal 2025, a net profit margin of −9.9%; its operating margin was 1.8%.
What is Albemarle's gross margin?
Albemarle's gross margin was 13.1% in fiscal 2025: for every $100 of revenue, Albemarle kept $13 after the direct cost of its products and services.
How much does Albemarle spend on research and development?
Albemarle spent $51.4 million on research and development in fiscal 2025, 1.0% of revenue.
How fast is Albemarle growing?
Revenue grew 10.4% a year on average over the last five fiscal years, from $3.1 billion to $5.1 billion.
What are Albemarle's earnings per share?
Albemarle earned $-0.79 per diluted share in fiscal 2025, compared with $-2.34 a year earlier.
When will Albemarle report its next earnings?
Albemarle is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes.
When does Albemarle's fiscal year end?
Albemarle's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 11, 2026.